Pluri (PLUR) Total Non-Current Liabilities (2011 - 2025)

Pluri (PLUR) reported Total Non-Current Liabilities of $7.5 million for Q4 2025, down 74.56% year-over-year from $29.3 million in Q4 2024, and up 4.25% quarter-over-quarter from $7.2 million in Q3 2025.

Pluri (PLUR) Total Non-Current Liabilities (2011 - 2025) Analysis & Trends

Pluri (PLUR) has 15 years of Total Non-Current Liabilities data on file, last reported at $7.5 million in Q4 2025.

  • Total Non-Current Liabilities for Q4 2025 came in at $7.5 million, down 74.56% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.5 million (down 74.56% YoY), and the FY2025 annual result was $7.2 million, down 75.66% from the prior year.
  • Total Non-Current Liabilities rose to $7.5 million in Q4 2025 per PLUR's latest filing, from $7.2 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $31.7 million in Q4 2021 and troughed at $1.1 million in Q1 2021.
  • A 5-year average of $24.6 million and a median of $29.5 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2021 and 2025: Total Non-Current Liabilities surged 2737.27% in 2021, then slumped 76.85% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $31.7 million in 2021, then dropped by 6.53% to $29.7 million in 2022, then gained by 2.49% to $30.4 million in 2023, then dropped by 3.55% to $29.3 million in 2024, then sank by 74.56% to $7.5 million in 2025.
  • Business Quant data shows PLUR's Total Non-Current Liabilities at $7.5 million in Q4 2025, $7.2 million in Q3 2025, and $7.2 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 42,980.09
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 11.03 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 95.20 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 644,700.00
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 5.87 Bn
9 Abivax 94.37 Bn 94.37 Bn - 64.76 Mn
10 Pluri 21.39 Mn 21.87 Mn 86,000.00 7.46 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 7.46 Mn
Sep 30, 2025 7.16 Mn
Jun 30, 2025 7.22 Mn
Mar 31, 2025 31.22 Mn
Dec 31, 2024 29.34 Mn
Sep 30, 2024 30.92 Mn
Jun 30, 2024 29.66 Mn
Mar 31, 2024 30.02 Mn
Dec 31, 2023 30.42 Mn
Sep 30, 2023 29.18 Mn
Jun 30, 2023 29.88 Mn
Mar 31, 2023 29.98 Mn
Dec 31, 2022 29.68 Mn
Sep 30, 2022 27.84 Mn
Jun 30, 2022 29.05 Mn
Mar 31, 2022 31.16 Mn
Dec 31, 2021 31.75 Mn
Sep 30, 2021 24.48 Mn
Jun 30, 2021 24.87 Mn
Mar 31, 2021 1.12 Mn